You
FiltersClear all
Kind

Style

Leads with

Best for

Industry

Origin

Era · first seen
Uses first seen. Date created is rarely published.
Length

50 closest statements

by meaning · ranked by similarity · 100 per page

Meaning search returns the 50 nearest statements, then applies your filters.

EQ
EQRx, Inc.Company · Health · MA
Real
“Our mission is to improve health for all with great, innovative, affordable medicines so that people with life-changing or chronic conditions can gain access to the medicines they need, physicians can treat patients without barriers to prescribing, and health systems can afford to make those medicines available, without restrictions, to the populations they serve in a financially sustainable manner.”
MissionDemocratizationLeads with accessMission-driven
In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-2352% match
RM
Regenerative Medical Technology Group Inc.Company · Retail & consumer · FL
Real
“Our mission is to empower physicians globally to deliver the transformative benefits of regenerative medicine—stem cell therapies, exosomes, peptides, and advanced combination protocols—to patients seeking effective, natural alternatives to traditional surgical, palliative, or symptom-management approaches.”
MissionImpactLeads with changeMission-driven
In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-05-1449% match
6D
60 Degrees Pharmaceuticals, Inc.Company · Health · DC
Real
“Our mission is to address the unmet medical need associated with vector-borne diseases through the development and commercialization of new small molecule therapeutics, focusing on synthetic drugs (made by chemists in labs, excluding biologics) with good safety profiles based on prior clinical studies, in order to reduce cost, risk, and capitalize on existing research.”
MissionProblem–solutionLeads with problemClimate & health
In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-3049% match
HB
Hoverink Biotechnologies, Inc.Company · Health · CA
Real
“Our mission is to improve the lives of patients who suffer from rare diseases for which there are limited or no available treatments, with an initial therapeutic focus on Cirrhosis ascites, patients suffering from AIDS, Cancer and chronic pain, nausea and discomfort associated with chemotherapy and neuropathy.”
MissionImpactLeads with changeMission-driven
In use 2017 – now·1 sighting·SEC Form 10-K, filed 2017-11-0649% match
Showing 1–50 of 50
0 to compareCompare